Incidental Prostate Cancer: A Real Need for Expansion in Guidelines?
- PMID: 34020930
- DOI: 10.1016/j.euo.2021.04.006
Incidental Prostate Cancer: A Real Need for Expansion in Guidelines?
Comment in
-
Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited.Eur Urol Oncol. 2022 Apr;5(2):261-262. doi: 10.1016/j.euo.2021.05.004. Epub 2021 Jun 1. Eur Urol Oncol. 2022. PMID: 34083164 No abstract available.
Comment on
-
Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines.Eur Urol Oncol. 2022 Apr;5(2):256-258. doi: 10.1016/j.euo.2021.03.005. Epub 2021 Apr 1. Eur Urol Oncol. 2022. PMID: 33814342 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical